http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2426533-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5235a4fb7c777e413667c99df505b23e |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-355 |
| filingDate | 2010-02-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2011-08-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_80737e9422560197680a4adcaba11b40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8739b467d0843e65dd868f8af3eaac26 |
| publicationDate | 2011-08-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2426533-C1 |
| titleOfInvention | Method of correcting anemia induced by introduction of preparation dapsone, in experiment |
| abstract | FIELD: medicine. ^ SUBSTANCE: invention relates to field of medicine, namely to dermatology and leprology, and deals with correction of anemia, induced by introduction of preparation dapsone in experiment. For this purpose used is alpha-tocopherol acetate, which is introduced in combination with dapsone to white non-linear male rats per os in dose 2-10 mg/kg 1 time per day for 21 days. ^ EFFECT: mode of alpha-tocopherol acetate ensures efficient correction of dapsone-induced hemolytic anemia, with absent side effects. ^ 5 ex, 5 tbl |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2525180-C1 |
| priorityDate | 2010-02-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 221.